Pathologic complete response after Sintilimab combined with FOLFOX therapy in MSI-H type patients with locally advanced GC: a case report
As one of the most common gastrointestinal tumors, Gastric Cancer (GC) poses a serious threat to human health due to its high morbidity and mortality. The current treatment strategy is a comprehensive treatment program mainly based on surgery, especially for advanced GC patients. The emergence of im...
Saved in:
| Main Authors: | Xiaoke Wang, Yuanhui Gu, Lin Yi, Tao Wu, Ling Wang, Jiao Tian, Yuyuan Lu, Penghui Jin, Xin Yang, Yan Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1560450/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Certain pMMR colorectal cancer patients should undergo additional MSI-PCR testing to reduce the risk of misdiagnosing MSI-H and Lynch syndrome
by: Jinglin Huang, et al.
Published: (2025-07-01) -
The effect of Entamoeba histolytica lectin antigen and microRNA-643 on the development of microsatellite instability (MSI) in colorectal adenocarcinoma
by: Leila Haghighi, et al.
Published: (2025-04-01) -
Monitoring active fires in Borneo from Sentinel-2 MSI images
by: Xiaoxiao Guo, et al.
Published: (2025-12-01) -
Correlation between dyslipidaemia and gastric cancer: pathogenesis to prevention and treatment strategies
by: Tao Wu, et al.
Published: (2025-06-01) -
Impact of body composition on pathological response to neoadjuvant immunotherapy in dMMR/MSI-H colorectal cancer
by: Ziyang Zeng, et al.
Published: (2025-05-01)